内镜下黏膜切除或食管切除术治疗黏膜下食管腺癌的结局
该研究比较了治疗性内镜下黏膜切除(EMR)与食管切除术治疗黏膜下食管腺癌的肿瘤学结局。72例患者中23例行EMR保留食管,49例行食管切除术,中位随访43个月。保留食管与局部复发风险增加相关(P = .01),但远处复发无差异(P = .44);倾向性匹配后远处复发率仍无差异(P = .66)。低危患者两种策略均获良好肿瘤控制,高危患者EMR后远处复发有增加趋势。
要点
- 保留食管的治疗性EMR与局部复发风险增加相关(P = .01)。
- 食管切除术后远处复发率与EMR相比无显著差异(P = .44)。
- 低危患者两种策略均获良好肿瘤控制,高危患者EMR后远处复发有增加趋势。
核心结论
- 治疗性EMR后保留食管与局部复发风险增加相关;低危患者两种策略均获良好肿瘤控制,高危患者保留食管显示远处失败增加趋势;这些发现应促使进一步研究以确定黏膜下食管腺癌的最佳治疗。
研究设计与样本
- 从科室数据库识别2007年至2015年接受治疗性EMR或食管切除术且病理分期为黏膜下腺癌的患者,进行非匹配及倾向性匹配队列的癌症相关结局比较,并使用风险分层比较低、中、高危淋巴结转移风险患者的结局。
主要发现
- 72例患者符合分析标准,其中23例行治疗性EMR保留食管,49例行食管切除术;中位随访43个月。
- 接受食管切除术的患者肿瘤更大、更深。
- 保留食管与局部复发风险增加相关(P = .01),但与远处复发无关(P = .44)。
- 倾向性匹配后,远处复发率仍无差异(P = .66)。
- 风险分层分析中,低危患者无复发或癌症相关死亡;高危患者治疗性EMR后远处复发有增加趋势。
临床怎么用
- 原文未据此给出推荐,作者指出这些发现应促使进一步研究以确定黏膜下食管腺癌的最佳治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Endoscopic mucosal resection (EMR) is a diagnostic and potentially therapeutic option for patients with submucosal esophageal adenocarcinoma. However, there are significant concerns regarding the risk of lymph node metastasis. Our purpose was to construct a comparative effectiveness analysis comparing recurrence patterns after therapeutic EMR or esophagectomy. METHODS: Patients who underwent therapeutic EMR or esophagectomy from 2007 to 2015 with pathologically staged submucosal adenocarcinoma were identified from a departmental database. Cancer-related outcomes were compared among an unmatched as well as a propensity matched cohort. Risk stratification was also used to compare results among those with a low, medium, or high risk of nodal metastasis. RESULTS: Seventy-two patients met criteria for analysis, among whom 23 underwent therapeutic EMR with esophageal preservation and 49 underwent esophagectomy. Median follow-up was 43 months. Patients who underwent esophagectomy had larger, deeper tumors. Esophageal preservation was associated with an increased risk of local recurrence (P = .01), but not distant recurrence (P = .44). After propensity matching, there continued to be no difference in distant recurrence rate (P = .66). In a risk-stratified analysis, low-risk patients showed no recurrences or cancer-related deaths, however, high-risk patients showed a trend toward increased distant recurrence after therapeutic EMR. CONCLUSIONS: Esophageal preservation after therapeutic EMR was associated with an increased risk of local recurrence. Among low-risk patients, either strategy resulted in excellent cancer control. However, among high-risk patients, esophageal preservation showed a trend toward increased distant failure. These findings should prompt further investigation to determine optimal treatment for patients with submucosal esophageal adenocarcinoma.
引用
- Nelson DB, Dhupar R, Katkhuda R, et al. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2018. PMID: 29605441. doi:10.1016/j.jtcvs.2018.02.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。